Clinical Trials Directory

Trials / Completed

CompletedNCT05124821

Evaluation of Performance Over Dwell Time and Safety of the Central-venous Catheters Certofix® Paed

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
B. Braun Melsungen AG · Industry
Sex
All
Age
1 Day – 17 Years
Healthy volunteers
Not accepted

Summary

Central venous catheterisation is a medical technique that has become established over many decades and can be rated as State of the Art. However, there is only few clinical evidence for the use of Certofix® Paed and additional clinical data need to be collected to underline the long-term performance and safety in paediatric patients. An updated summary overview of Binninger and Roschke describes the potential incidence rates of the classically catheter-related complications, e.g. catheter malposition, catheter fracture, occlusion, thrombosis and catheter-related bloodstream infections (CRBSI) which may have an impact on overall morbidity, mortality and treatment costs. These catheter-related complications should be evaluated in this non-interventional study in paediatric patients.

Conditions

Interventions

TypeNameDescription
DEVICECentral venous catheter intended to be used for children during routine clinical practiceDevice will applied according to instruction for use (IFU) and respective indication during routine clinical practice.

Timeline

Start date
2023-05-19
Primary completion
2024-04-22
Completion
2024-04-22
First posted
2021-11-18
Last updated
2024-06-13

Locations

3 sites across 2 countries: Germany, Italy

Source: ClinicalTrials.gov record NCT05124821. Inclusion in this directory is not an endorsement.